# A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula

> **NCT04519827** · NA · COMPLETED · sponsor: **Dr. Schär AG / SPA** · enrollment: 39 (actual)

## Conditions studied

- Allergy;Food

## Interventions

- **OTHER:** New Rice-based hydrolysate
- **OTHER:** Amino Acid-based infant formula

## Key facts

- **NCT ID:** NCT04519827
- **Lead sponsor:** Dr. Schär AG / SPA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-21
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519827, "A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04519827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*